Aschoff, L. Zur Morphologie der lipoiden Substanzen. Beitr. Pathol. Anat. Allg. Pathol. 47, 1–50 (1910).

Google Scholar 

Levene, C. I. The early lesions of atheroma in the coronary arteries. J. Pathol. Bacteriol. 72, 79–82 (1956).

Article  CAS  PubMed  Google Scholar 

Luo, Y. et al. Modeling of mechanical stress exerted by cholesterol crystallization on atherosclerotic plaques. PLoS ONE 11, e0155117 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Kiyak, J. H. Cholesterol crystals, smooth muscle cells and new data on the genesis of atherosclerosis. Pol. J. Pathol. 48, 49–55 (1997).

CAS  PubMed  Google Scholar 

Varsano, N. et al. Two polymorphic cholesterol monohydrate crystal structures form in macrophage culture models of atherosclerosis. Proc. Natl Acad. Sci. USA 115, 7662–7669 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vedre, A. et al. Physical factors that trigger cholesterol crystallization leading to plaque rupture. Atherosclerosis 203, 89–96 (2009).

Article  CAS  PubMed  Google Scholar 

Katz, S. S., Shipley, G. G. & Small, D. M. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J. Clin. Invest. 58, 200–211 (1976).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bogren, H. & Larsson, K. An X-ray-diffraction study of crystalline cholesterol in some pathological deposits in man. Biochim. Biophys. Acta 75, 65–69 (1963).

Article  CAS  PubMed  Google Scholar 

Park, M. H. et al. Non-linear optical imaging of atherosclerotic plaques in the context of SIV and HIV infection prominently detects crystalline cholesterol esters. PLoS ONE 16, e0251599 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baumer, Y., McCurdy, S. G. & Boisvert, W. A. Formation and cellular impact of cholesterol crystals in health and disease. Adv. Biol. 5, e2100638 (2021).

Article  Google Scholar 

Abela, G. S. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. J. Clin. Lipidol. 4, 156–164 (2010).

Article  PubMed  Google Scholar 

Baumer, Y. et al. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat. Commun. 8, 1129 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Venturelli, C., Jeannin, G., Sottini, L., Dallera, N. & Scolari, F. Cholesterol crystal embolism (atheroembolism). Heart Int. 2, 155 (2006).

Article  PubMed  PubMed Central  Google Scholar 

Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ioannou, G. N. et al. Cholesterol crystals in hepatocyte lipid droplets are strongly associated with human nonalcoholic steatohepatitis. Hepatol. Commun. 3, 776–791 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koka, S. et al. Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia. Redox Biol. 13, 336–344 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajamäki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 5, e11765 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Wang, R. et al. Activation of NLRP3 inflammasome promotes foam cell formation in vascular smooth muscle cells and atherogenesis via HMGB1. J. Am. Heart Assoc. 7, e008596 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Jones, G. T. in Diagnosis, Screening and Treatment of Abdominal, Thoracoabdominal and Thoracic Aortic Aneurysms Ch. 3 (ed. Grundmann, R. T.) (IntechOpen, 2011).

Abela, G. S. & Aziz, K. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events – a novel insight into plaque rupture by scanning electron microscopy. Scanning 28, 1–10 (2006).

Article  CAS  PubMed  Google Scholar 

Furukawa, E. et al. The impact of chronic kidney disease on cholesterol crystal embolism in autopsy cases [abstract]. Nephrol. Dial. Transplant. 34 (Suppl. 1), gfz106.FP072 (2019).

Article  Google Scholar 

Haas, M., Spargo, B. H., Wit, E. J. & Meehan, S. M. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am. J. Kidney Dis. 35, 433–447 (2000).

Article  CAS  PubMed  Google Scholar 

Li, X., Bayliss, G. & Zhuang, S. Cholesterol crystal embolism and chronic kidney disease. Int. J. Mol. Sci. 18, 1120 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Shroff, H. & VanWagner, L. B. Cardiovascular disease in nonalcoholic steatohepatitis: screening and management. Curr. Hepatol. Rep. 19, 315–326 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Hammer, S. S. et al. Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy. Diabetologia 66, 1705–1718 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walton, K. W. & Dunkerley, D. J. Studies on the pathogenesis of corneal arcus formation II. Immunofluorescent studies on lipid deposition in the eye of the lipid-fed rabbit. J. Pathol. 114, 217–229 (1974).

Article  CAS  PubMed  Google Scholar 

Silva, G. B. et al. Cholesterol crystals and NLRP3 mediated inflammation in the uterine wall decidua in normal and preeclamptic pregnancies. Front. Immunol. 11, 564712 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Virchow, R. L. K. Cellular Pathology (John Churchill, 1860).

Marchand, F. Ueber atherosclerosis. Verhandlungen der Kongresse fuer Innere Medizin Vol. 21 (1904).

Ridker, P. M. How common is residual inflammatory risk? Circ. Res. 120, 617–619 (2017).

Article  CAS  PubMed  Google Scholar 

Aday, A. W. & Ridker, P. M. Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease. Front. Cardiovasc. Med. 6, 16 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).

Article  CAS  PubMed  Google Scholar 

Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A. & Thompson, P. L. Low-dose colchicine for secondary prevention of cardiovascular disease. J. Am. Coll. Cardiol. 61, 404–410 (2013).

Article  CAS  PubMed  Google Scholar 

Tardif, J. C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381, 2497–2505 (2019).

Article  CAS  PubMed  Google Scholar 

Nidorf, S. M. et al. Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 383, 1838–1847 (2020).

Article